Changes in the subcellular localization of the Brn4 gene product precede mesenchymal remodeling of the otic capsule

Hearing Research

Volumn 120, Issue 1-2, 1998, Pages 77-85

  Phippard, Deborah ^a   Heydemann, Ahlke ^b   Lechner, Mark ^b   Lu, Lihui ^a   Lee, Daniel ^a   Kyin, Tim ^a   Crenshaw III, E Bryan ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Brain 4 (Brn4 Pou3f4); Immunohistochemistry; In situ hybridization; Otic capsule; Temporal bone formation

Indexed keywords

GENE PRODUCT;

ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; COCHLEA; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INNER EAR; INTERNAL AUDITORY CANAL; MESENCHYME; MOUSE; NONHUMAN; PRIORITY JOURNAL; TEMPORAL BONE; VESTIBULAR SYSTEM;

ANIMALS; DNA-BINDING PROTEINS; EAR, INNER; EMBRYONIC AND FETAL DEVELOPMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MESODERM; MICE; NERVE TISSUE PROTEINS; POU DOMAIN FACTORS; SCALA TYMPANI; TEMPORAL BONE; TRANSCRIPTION FACTORS; VESTIBULE;

EID: 0031833596     PISSN: 03785955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5955(98)00059-8     Document Type: Article

References (25)

1. Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.M., Seidman, J.G., Smith, J.A., Struhl, K., 1991. Current Protocols in Molecular Biology, Greene Publishing Associates and Wiley-Interscience, New York.
2. Baeuerle P.A., Baltimore D. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science. 242:1988;540-546.
3. de Kok Y.J., van der Maarel S.M., Bitner-Glindzicz M., Huber I., Monaco A.P., Malcolm S., Pembrey M.E., Ropers H.H., Cremers F.P. Association between X-linked mixed deafness and mutations in the POU domain gene POU3F4. Science. 267:1995;685-688.
4. Frenz D.A., Van de Water T.R. Epithelial control of periotic mesenchyme chondrogenesis. Dev. Biol. 144:1991;38-46.
5. Frenz D.A., Galinovic-Schwartz V., Staecker H., Van de Water T.R. Transforming growth factor-beta. Paracrine mediator of otic capsule formation. Ann. NY Acad. Sci. 630:1991;253-255.
6. Frenz D.A., Van de Water T.R., Galinovic Schwartz V. Transforming growth factor beta: does it direct otic capsule formation? Ann. Otol. Rhinol. Laryngol. 100:(4Pti):1991;301-307.
7. Frenz D.A., Williams J.D., Van de Water T.R. Initiation of chondrogenesis in cultured periotic mesenchyme. Synergistic action of transforming growth factor-beta and fibroblast growth factor. Ann. NY Acad. Sci. 630:1991;256-258.
8. Frenz D.A., Galinovic-Schwartz V., Liu W., Flanders K.C., Van de Water T.R. Transforming growth factor beta 1 is an epithelial-derived signal peptide that influences otic capsule formation. Dev. Biol. 153:1992;324-336.
9. Frenz D.A., Liu W., Williams J.D., Hatcher V., Galinovic S.V., Flanders K.C., Van de Water T.R. Induction of chondrogenesis: requirement for synergistic interaction of basic fibroblast growth factor and transforming growth factor-beta. Development. 120:1994;415-424.
10. Guan K.L., Dixon J.E. Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase. Anal. Biochem. 192:1991;262-267.
11. Herr W., Cleary M.A. The POU domain: versatility in transcriptional regulation by a flexible two-in-one DNA-binding domain. Genes Dev. 9:1995;1679-1693.
12. Langman, J., 1982. Medical Embryology, Williams and Wilkins, Baltimore, MD.
13. McPhee J.R., Van de Water T.R. A comparison of morphological stages and sulfated glycosaminoglycan production during otic capsule formation: in vivo and in vitro. Anat. Rec. 213:1985;566-577.
14. McPhee J.R., Van de Water T.R. Epithelial-mesenchymal tissue interactions guiding otic capsule formation: the role of the otocyst. J. Embryol. Exp. Morphol. 97:1986;1-24.
15. Piussan C., Hanauer A., Dahl N., Mathieu M., Kolski C., Biancalana V., Heyberger S., Strunski V. X-linked progressive mixed deafness: a new microdeletion that involves a more proximal region in Xq21. Am. J. Hum. Genet. 56:1995;224-230.
16. Rushlow C., Warrior R. The rel family of proteins. BioEssays. 14:1992;89-95.
17. Sher A.E. The embryonic and postnatal development of the inner ear of the mouse. Acta Otolaryngol. (Suppl.). 285:1971;1-77.
18. Shull M.M., Ormsby I., Kier A.B., Pawlowski S., Diebold R.J., Yin M., Allen R., Sidman C., Proetzel G., Calvin D., et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature. 359:1992;693-699.
19. Simmons D.M., Arriza J.L., Swanson L.W. A complete protocol for in situ hybridization of messenger RNAs in brain and other tissues with radio-labeled single-stranded RNA probes. J. Histotechnol. 12:1989;169-181.
20. Steel K.P., Brown S.D. Genes and deafness [Review]. Trends Genet. 10:1994;428-435.
21. Theiler, K., 1989. The House Mouse: Atlas of Embryonic Development, 2nd edn., Springer-Verlag, New York.
22. Treacy M.N., Rosenfeld M.G. Expression of a family of POU-domain protein regulatory genes during development of the central nervous system. Annu. Rev. Neurosci. 15:1992;139-165.
23. Van de Water T.R., Represa J. Tissue interactions and growth factors that control development of the inner ear. Neural tube-otic anlage interaction. Ann. NY Acad. Sci. 630:1991;116-128.
24. Verrijzer C.P., Van der Vliet P.C. POU domain transcription factors. Biochim. Biophys. Acta. 1173:1993;1-21.
25. Wegner M., Drolet D.W., Rosenfeld M.G. POU-domain proteins: structure and function of developmental regulators. Curr. Opin. Cell Biol. 5:1993;488-498.